CLINICAL TRIALS PROFILE FOR LOMAIRA
✉ Email this page to a colleague
All Clinical Trials for LOMAIRA
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT03374956 ↗ | Individualized Obesity Pharmacotherapy | Active, not recruiting | Mayo Clinic | Phase 3 | 2017-12-11 | The researchers are trying to identify the specific characteristics (phenotypes) that may be useful to help select the right medication for weight loss. |
| NCT04095104 ↗ | Adjunct Phentermine + Topiramate After Bariatric Surgery in 12-24 Year Olds | Recruiting | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 2 | 2020-01-15 | The goal of this pilot study is to establish the feasibility and initial efficacy of the combination of phentermine and topiramate for adolescents and young adults who require additional risk reduction after bariatric surgery. This study will use a randomized, placebo-controlled, double-blinded design to evaluate an adjunctive 12-week intervention of phentermine + topiramate + standard of care vs. placebos + standard of care 6 months after bariatric surgery, among 12 to 24 year olds who don't achieve expected weight loss or who remain severely obese (n=10 total). |
| NCT04095104 ↗ | Adjunct Phentermine + Topiramate After Bariatric Surgery in 12-24 Year Olds | Recruiting | University of Colorado- Clinical and Translational Sciences Institute | Phase 2 | 2020-01-15 | The goal of this pilot study is to establish the feasibility and initial efficacy of the combination of phentermine and topiramate for adolescents and young adults who require additional risk reduction after bariatric surgery. This study will use a randomized, placebo-controlled, double-blinded design to evaluate an adjunctive 12-week intervention of phentermine + topiramate + standard of care vs. placebos + standard of care 6 months after bariatric surgery, among 12 to 24 year olds who don't achieve expected weight loss or who remain severely obese (n=10 total). |
| NCT04095104 ↗ | Adjunct Phentermine + Topiramate After Bariatric Surgery in 12-24 Year Olds | Recruiting | University of Colorado- Nutrition Obesity Research Center | Phase 2 | 2020-01-15 | The goal of this pilot study is to establish the feasibility and initial efficacy of the combination of phentermine and topiramate for adolescents and young adults who require additional risk reduction after bariatric surgery. This study will use a randomized, placebo-controlled, double-blinded design to evaluate an adjunctive 12-week intervention of phentermine + topiramate + standard of care vs. placebos + standard of care 6 months after bariatric surgery, among 12 to 24 year olds who don't achieve expected weight loss or who remain severely obese (n=10 total). |
| NCT04095104 ↗ | Adjunct Phentermine + Topiramate After Bariatric Surgery in 12-24 Year Olds | Recruiting | Jaime Moore, MD MPH | Phase 2 | 2020-01-15 | The goal of this pilot study is to establish the feasibility and initial efficacy of the combination of phentermine and topiramate for adolescents and young adults who require additional risk reduction after bariatric surgery. This study will use a randomized, placebo-controlled, double-blinded design to evaluate an adjunctive 12-week intervention of phentermine + topiramate + standard of care vs. placebos + standard of care 6 months after bariatric surgery, among 12 to 24 year olds who don't achieve expected weight loss or who remain severely obese (n=10 total). |
| NCT04614545 ↗ | Comparing a Virtual vs. Face to Face Weight Management Program Using Phentermine for Patients With Overweight or Obesity | Active, not recruiting | The Cleveland Clinic | Phase 4 | 2021-01-01 | This study will study the effects associated with the prescription of phentermine in a virtual setting, comparing with prescription of phentermine via a standard face-to-face visit for patients with obesity or overweight. |
| NCT05176626 ↗ | Long-term Effectiveness of the Antiobesity Medication Phentermine | Not yet recruiting | Biomedical Research Institute of New Mexico | Phase 4 | 2022-06-01 | The purpose of this research study is to understand the long-term effects of the drug phentermine on weight, blood pressure, other health outcomes, and safety. Phentermine has been approved by the US Food and Drug Administration (FDA) for weight management since 1959, but it has not been approved for long-term use (i.e., treatment lasting more than 12 weeks). This trial is designed to learn about the long-term effects of phentermine for up to 2 years because obesity is a chronic disease and expert guidelines recommend long-term use of anti-obesity medications as one treatment option. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for LOMAIRA
Condition Name
Clinical Trial Locations for LOMAIRA
Trials by Country
Clinical Trial Progress for LOMAIRA
Clinical Trial Phase
Clinical Trial Sponsors for LOMAIRA
Sponsor Name
